97 related articles for article (PubMed ID: 3325297)
1. Fasting and L-364,718 prevent cholecystokinin-induced elevations of plasma insulin levels.
Reagan JE; Robinson JL; Lotti VJ; Goldman ME
Eur J Pharmacol; 1987 Dec; 144(2):241-3. PubMed ID: 3325297
[TBL] [Abstract][Full Text] [Related]
2. Activation of CCK-A receptors induces elevation of plasma corticosterone in rats.
Katsuura G; Ibii N; Matsushita A
Peptides; 1992; 13(1):203-5. PubMed ID: 1620654
[TBL] [Abstract][Full Text] [Related]
3. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.
Hirosue Y; Inui A; Miura M; Nakajima M; Okita M; Himori N; Baba S; Kasuga M
Peptides; 1992; 13(1):155-7. PubMed ID: 1620653
[TBL] [Abstract][Full Text] [Related]
4. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors.
Karlsson S; Ahrén B
Eur J Pharmacol; 1992 Mar; 213(1):145-6. PubMed ID: 1499651
[TBL] [Abstract][Full Text] [Related]
5. Effects of diet and the cholecystokinin antagonist; devazepide (L364,718) on CCK mRNA, and tissue and plasma CCK concentrations.
Playford RJ; King AW; Deprez PH; De-Belleroche J; Freeman TC; Calam J
Eur J Clin Invest; 1993 Oct; 23(10):641-7. PubMed ID: 8281982
[TBL] [Abstract][Full Text] [Related]
6. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
7. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
Reidelberger RD; O'Rourke MF
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin octapeptide decreases food intake in white-crowned sparrows.
Richardson RD; Boswell T; Weatherford SC; Wingfield JC; Woods SC
Am J Physiol; 1993 May; 264(5 Pt 2):R852-6. PubMed ID: 8498593
[TBL] [Abstract][Full Text] [Related]
9. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
O'Neill MF; Dourish CT; Iversen SD
Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
[TBL] [Abstract][Full Text] [Related]
11. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
O'Rourke MF; Reidelberger RD; Solomon TE
Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
[TBL] [Abstract][Full Text] [Related]
12. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
13. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
Altar CA; Boyar WC
Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
[TBL] [Abstract][Full Text] [Related]
15. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
Green T; Dimaline R; Peikin S; Dockray GJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
[TBL] [Abstract][Full Text] [Related]
16. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
Rossetti L; Shulman GI; Zawalich WS
Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
18. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
[TBL] [Abstract][Full Text] [Related]
19. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
